Gefitinib for Patients with Incurable Cutaneous Squamous Cell Carcinoma A Single Arm Phase II Clinical Trial

BACKGROUND: Pre-clinical data demonstrate a key role for the epidermal growth factor receptor (EGFR) in the carcinogenesis of cutaneous squamous cell carcinomas (CSCC). There is, however, limited data on the efficacy of EGFR inhibitors in incurable, recurrent and/or metastatic CSCC. OBJECTIVE: To de...

Full description

Saved in:
Bibliographic Details
Published in:J Am Acad Dermatol
Main Authors: William, William N., Feng, Lei, Ferrarotto, Renata, Ginsberg, Lawrence, Kies, Merrill, Lippman, Scott, Glisson, Bonnie, Kim, Edward S.
Format: Artigo
Language:Inglês
Published: 2017
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5685879/
https://ncbi.nlm.nih.gov/pubmed/28964539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaad.2017.07.048
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items